EL vs MBRX · rev $15.05B vs $8.2M cap
Estee Lauder Companies Inc (EL) versus Moleculin Biotech Inc (MBRX) — a side-by-side from cached financials, not a winner call.
Estee Lauder Companies Inc (EL) is a household & personal products company listed on US.
Moleculin Biotech Inc (MBRX) is a biotechnology company listed on US.
Latest reported EL revenue for 2026-06-30 was $15.05B. Net income was $182.0M. Revenue was up 5.0% from 2025-06-30 to 2026-06-30. EL currently screens at market cap $31.92B.
Latest reported MBRX revenue for 2026-06-30 was $0. Net income was -$20.5M. MBRX currently screens at market cap $8.2M.
EL currently screens at market cap $31.92B. MBRX currently screens at market cap $8.2M.
Not investment advice. Open the EL and MBRX stock pages for the full models.
Not investment advice.